To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
Condition(s):Attention Deficit/Hyperactivity Disorder; Bipolar DisorderLast Updated:June 1, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Attention Deficit/Hyperactivity Disorder; Bipolar DisorderLast Updated:June 1, 2012Completed
Condition(s):Peripheral Arterial DiseaseLast Updated:April 15, 2021Withdrawn
Condition(s):OverweightLast Updated:April 5, 2017Completed
Condition(s):Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate CancerLast Updated:August 9, 2018Withdrawn
Condition(s):HealthyLast Updated:September 16, 2019Completed
Condition(s):PreDiabetes; Obesity, Morbid; Diabetes Mellitus, Type 2Last Updated:September 2, 2020Unknown status
Condition(s):Gulf War IllnessLast Updated:September 11, 2018Unknown status
Condition(s):Skeletal DysplasiaLast Updated:August 14, 2023Recruiting
Condition(s):Obesity, Adolescent; Lifestyle, Healthy; Diet, Healthy; Cardiovascular Risk FactorLast Updated:August 1, 2023Active, not recruiting
Condition(s):OBESITY; INFLAMMATION; DYSLIPIDEMIA; CONSTIPATIONLast Updated:November 1, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.